JP2025510945A5 - - Google Patents
Info
- Publication number
- JP2025510945A5 JP2025510945A5 JP2024557461A JP2024557461A JP2025510945A5 JP 2025510945 A5 JP2025510945 A5 JP 2025510945A5 JP 2024557461 A JP2024557461 A JP 2024557461A JP 2024557461 A JP2024557461 A JP 2024557461A JP 2025510945 A5 JP2025510945 A5 JP 2025510945A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- optionally substituted
- independently
- iii
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/084377 | 2022-03-31 | ||
| PCT/CN2022/084377 WO2023184327A1 (en) | 2022-03-31 | 2022-03-31 | Kinase inhibitors, preparation methods and uses thereof |
| CNPCT/CN2022/118935 | 2022-09-15 | ||
| CN2022118935 | 2022-09-15 | ||
| PCT/CN2023/085320 WO2023186060A1 (en) | 2022-03-31 | 2023-03-31 | Kinase inhibitors, preparation methods and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510945A JP2025510945A (ja) | 2025-04-15 |
| JP2025510945A5 true JP2025510945A5 (enExample) | 2026-03-23 |
Family
ID=88199480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557461A Pending JP2025510945A (ja) | 2022-03-31 | 2023-03-31 | キナーゼ阻害剤、その製造方法および用途 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250223301A1 (enExample) |
| EP (1) | EP4499640A4 (enExample) |
| JP (1) | JP2025510945A (enExample) |
| CN (1) | CN118974049A (enExample) |
| WO (1) | WO2023186060A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL315015A (en) | 2022-03-01 | 2024-10-01 | Insilico Medicine Ip Ltd | Diacylglycerol kinase (DGK) alpha inhibitors and their uses |
| CN116969943A (zh) * | 2022-04-28 | 2023-10-31 | 轩竹生物科技股份有限公司 | 三并环类二酰甘油激酶抑制剂及其用途 |
| TW202436351A (zh) | 2023-02-06 | 2024-09-16 | 德商拜耳廠股份有限公司 | Ccr8抗體及dgk抑制劑之組合 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011522047A (ja) * | 2008-06-03 | 2011-07-28 | メルク・シャープ・エンド・ドーム・コーポレイション | Ａｋｔ活性の阻害剤 |
| WO2013009535A1 (en) * | 2011-07-08 | 2013-01-17 | Merck Sharp & Dohme Corp. | Il-23 antagonists for treatment or prevention of skin rash associated with treatment with p13k/akt pathway inhibitors |
| JP7677976B2 (ja) * | 2019-12-23 | 2025-05-15 | ブリストル－マイヤーズ スクイブ カンパニー | Ｔ細胞アクティベーターとして有用な置換ヘテロアリール化合物 |
| CN115362003B (zh) * | 2019-12-24 | 2024-03-22 | 卡尔那生物科学株式会社 | 二酰基甘油激酶调节化合物 |
| WO2021258010A1 (en) * | 2020-06-19 | 2021-12-23 | Gossamer Bio Services, Inc. | Oxime compounds useful as t cell activators |
| EP4359413A1 (en) * | 2021-06-23 | 2024-05-01 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
-
2023
- 2023-03-31 JP JP2024557461A patent/JP2025510945A/ja active Pending
- 2023-03-31 WO PCT/CN2023/085320 patent/WO2023186060A1/en not_active Ceased
- 2023-03-31 EP EP23778425.1A patent/EP4499640A4/en active Pending
- 2023-03-31 CN CN202380028014.1A patent/CN118974049A/zh active Pending
- 2023-03-31 US US18/852,249 patent/US20250223301A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6227707B2 (ja) | Ｍｃｌ‐１を調節する小分子、並びに細胞死、細胞分裂、細胞分化を調節する方法、及び疾患を治療する方法。 | |
| ES2292770T3 (es) | Derivados de fenilpirazoles en calidad de inhibidores de epoxido hidrolasa solubles. | |
| RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
| IL197135A (en) | The phenoxyphenylacetic acid derivatives are preserved in position 4, preparations containing them, their uses and methods for preparing them | |
| HRP20170638T1 (hr) | MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI | |
| RU2009115653A (ru) | Производные 5-замещенного хиназолинона, содержащие их композиции и способы их применения | |
| RU2019142795A (ru) | Производное n-(азаарил)циклолактам-1-карбоксамида, метод его получения и его применение | |
| CA2458035A1 (en) | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | |
| JP2013010792A5 (enExample) | ||
| EA202090658A1 (ru) | Ингибиторы кэп-зависимой эндонуклеазы | |
| CA2415486A1 (en) | Pyramidine derivatives | |
| ES2762193T3 (es) | Agonistas de proteína tirosina fosfatasa 1 que contiene dominio de homología Src-2 y métodos de tratamiento usando la misma | |
| RU2009105826A (ru) | 2,4-ди(ариламино)питимидин-5-карбоксамидные соединения в качестве ингибиторов jak-киназ | |
| JP2007508362A5 (enExample) | ||
| JPWO2002014265A1 (ja) | 新規３置換尿素誘導体およびその医薬としての用途 | |
| RU2009118254A (ru) | Фенилацетамиды в качестве ингибиторов протеинкиназ | |
| RU2008126245A (ru) | Комбинация ингибитора асне и антагониста 5-нт для лечения когнитивной дисфункции | |
| JP2019510025A5 (enExample) | ||
| RU2010115337A (ru) | Трициклические гетероциклические производные | |
| JP2024511389A5 (enExample) | ||
| RU2014132159A (ru) | Соединения 2-арилбензофуран-7-формамида, способ их получения и применение | |
| RU2014119705A (ru) | Пиридин-сульфоксимины в качестве ингибиторов киназы | |
| CN102170882B (zh) | 治疗淀粉状蛋白疾病的组合物和其制药用途 | |
| JP2009514899A5 (enExample) | ||
| JP2020528922A5 (enExample) |